State Street SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
56.25
-0.15 (-0.27%)
Dec 12, 2025, 4:00 PM EST - Market closed
XPH Holdings Information
XPH is an equity ETF with a total of 52 individual holdings. The top holdings are Terns Pharmaceuticals stock at 4.00%, Nuvation Bio at 3.34%, Tarsus Pharmaceuticals at 3.30%, Crinetics Pharmaceuticals at 3.09%, and Eli Lilly and Company at 2.93%.
Total Holdings
25
Top 10 Percentage
30.24%
Asset Class
Equity
ETF Category
Health
Assets
222.54M
PE Ratio
16.73
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TERN | Terns Pharmaceuticals, Inc. | 4.00% |
| 2 | NUVB | Nuvation Bio Inc. | 3.34% |
| 3 | TARS | Tarsus Pharmaceuticals, Inc. | 3.30% |
| 4 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.09% |
| 5 | LLY | Eli Lilly and Company | 2.93% |
| 6 | JAZZ | Jazz Pharmaceuticals plc | 2.85% |
| 7 | WVE | Wave Life Sciences Ltd. | 2.82% |
| 8 | CORT | Corcept Therapeutics Incorporated | 2.67% |
| 9 | AXSM | Axsome Therapeutics, Inc. | 2.63% |
| 10 | JNJ | Johnson & Johnson | 2.62% |
| 11 | LQDA | Liquidia Corporation | 2.62% |
| 12 | HRMY | Harmony Biosciences Holdings, Inc. | 2.61% |
| 13 | MRK | Merck & Co., Inc. | 2.58% |
| 14 | ELAN | Elanco Animal Health Incorporated | 2.54% |
| 15 | VTRS | Viatris Inc. | 2.48% |
| 16 | OCUL | Ocular Therapeutix, Inc. | 2.46% |
| 17 | LGND | Ligand Pharmaceuticals Incorporated | 2.42% |
| 18 | BMY | Bristol-Myers Squibb Company | 2.38% |
| 19 | HROW | Harrow, Inc. | 2.37% |
| 20 | RPRX | Royalty Pharma plc | 2.35% |
| 21 | AVDL | Avadel Pharmaceuticals plc | 2.32% |
| 22 | PFE | Pfizer Inc. | 2.30% |
| 23 | SUPN | Supernus Pharmaceuticals, Inc. | 2.21% |
| 24 | INVA | Innoviva, Inc. | 2.16% |
| 25 | PBH | Prestige Consumer Healthcare Inc. | 2.05% |
As of Dec 11, 2025